Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5258 publications
Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: October 15, 2025
Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report.
Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report.
Journal: Turk psikiyatri dergisi = Turkish journal of psychiatry
Published: October 10, 2025
Efficacy and adverse effect profile of vortioxetine in major depressive disorder: A meta-analysis.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 08, 2025
Successful multimodal treatment of venlafaxine overdose-induced catecholamine-refractory shock: a case report.
Journal: The Journal of toxicological sciences
Published: October 01, 2025
Benefits of duloxetine may outweigh risks in a patient with hormone-positive breast cancer.
Journal: Palliative & supportive care
Published: September 17, 2025
An environmental risk assessment of contamination of lakes and rivers in Northern Ireland with pharmaceuticals, personal care products and drugs of abuse.
Journal: Environmental science. Processes & impacts
Published: September 16, 2025
Advanced strategies for the removal of venlafaxine from aqueous environments: a critical review of adsorption and advanced oxidation pathways.
Journal: RSC advances
Published: September 15, 2025
Antidepressants Target the ST3GAL5-GM3 Lipid Pathway to Suppress Microglial Inflammation.
Journal: International journal of molecular sciences
Published: August 27, 2025
Allostatic load in major depressive disorder: An in-patient clinical study.
Journal: Psychoneuroendocrinology
Published: August 25, 2025
Detection and in silico evaluation of undeclared venlafaxine and clomethiazole in a counterfeit herbal product marketed for alcohol withdrawal syndrome.
Journal: Journal of pharmaceutical and biomedical analysis
Published: August 15, 2025
Last Updated: 10/31/2025